Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Colorectal Neoplasms

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 93 articles: HTML format Text format

Single Articles

March 2010
1. EARLE CC , Chretien Y, Morris C, Ayanian JZ, et al
   Employment Among Survivors of Lung Cancer and Colorectal Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
2. CREMOLINI C , Loupakis F, Ruzzo A, Perrone G, et al
   Predictors of Benefit in Colorectal Cancer Treated With Cetuximab: Are We Getting "Lost in TranslationAL"?
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles   
   
   
   
3. FERNANDEZ-MARTOS C , Pericay C, Aparicio J, Salud A, et al
   Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-define
   J Clin Oncol. 2010;28:859-65.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. LACOUTURE ME , Mitchell EP, Piperdi B, Pillai MV, et al
   Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. MANNE SL , Meropol NJ, Weinberg DS, Vig H, et al
   Facilitating Informed Decisions Regarding Microsatellite Instability Testing Among High-Risk Individuals Diagnosed With Colorectal Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. MAEDA T , Cannom RR, Beart RW Jr, Etzioni DA, et al
   Decision Model of Segmental Compared With Total Abdominal Colectomy for Colon Cancer in Hereditary Nonpolyposis Colorectal Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. WATANABE T , Kobunai T, Yamamoto Y, Konishi T, et al
   Prognostic Significance of 18q Loss of Heterzygosity in Microsatellite-Stable Colorectal Cancer.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles   
   
   
   
8. CHU QD , Glass J
   Findings that hospital factors are surrogate for disparities are misleading.
   J Clin Oncol. 2010;28:e56.
   PubMed     Text format     Related articles   
   
   
   January 2010
9. TABERNERO J , Cervantes A, Rivera F, Martinelli E, et al
   Pharmacogenomic and Pharmacoproteomic Studies of Cetuximab in Metastatic Colorectal Cancer: Biomarker Analysis of a Phase I Dose-Escalation Study.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. BARDELLI A , Siena S
    Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. ALBERTS SR , Roh MS, Mahoney MR, O'Connell MJ, et al
    Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
12. TOFFOLI G , Cecchin E, Gasparini G, D'Andrea M, et al
    Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. DE GRAMONT A , Hubbard J, Shi Q, O'Connell MJ, et al
    Association Between Disease-Free Survival and Overall Survival When Survival Is Prolonged After Recurrence in Patients Receiving Cytotoxic Adjuvant Therapy for Colon Cancer: Simulations Based on the 20,800 Patient ACCENT Data Set.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. ROTH AD , Tejpar S, Delorenzi M, Yan P, et al
    Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. KOPETZ S , Hoff PM, Morris JS, Wolff RA, et al
    Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
16. GUNDERSON LL , Jessup JM, Sargent DJ, Greene FL, et al
    Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. KHATRI VP
    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer: A Panacea or Just an Obstacle Course for the Patient?
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
18. CHAO M , Gibbs P
    Caution Is Required Before Recommending Routine Carcinoembryonic Antigen and Imaging Follow-Up for Patients With Early-Stage Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
19. GONEN M , Schrag D, Weiser MR
    Nodal Staging Score: A Tool to Assess Adequate Staging of Node-Negative Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. LAURENT-PUIG P , Cayre A, Manceau G, Buc E, et al
    Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. RICHMAN SD , Seymour MT, Chambers P, Elliott F, et al
    KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. BERTAGNOLLI MM
    The Forest and the Trees: Pathways and Proteins As Colorectal Cancer Biomarkers.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    October 2009
23. PAGES F , Kirilovsky A, Mlecnik B, Asslaber M, et al
    In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. BRAUN MS , Richman SD, Thompson L, Daly CL, et al
    Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. WONG SL , Mangu PB, Choti MA, Crocenzi TS, et al
    American Society of Clinical Oncology 2009 Clinical Evidence Review on Radiofrequency Ablation of Hepatic Metastases From Colorectal Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. DE GRAMONT A , Haller DG, Sargent DJ, Tabernero J, et al
    Toward Efficient Trials in Colorectal Cancer: The ARCAD Clinical Trials Program.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
27. SHANKARAN V , Luu TH, Nonzee N, Richey E, et al
    Costs and Cost-Effectiveness of a Health Care Provider-Directed Intervention to Promote Colorectal Cancer Screening.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. CHANG GJ , Hu CY, Eng C, Skibber JM, et al
    Practical Application of a Calculator for Conditional Survival in Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
29. CHIBAUDEL B , Maindrault-Goebel F, Lledo G, Mineur L, et al
    Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. JACOBS B , De Roock W, Piessevaux H, Van Oirbeek R, et al
    Amphiregulin and Epiregulin mRNA Expression in Primary Tumors Predicts Outcome in Metastatic Colorectal Cancer Treated With Cetuximab.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. LIEBIG C , Ayala G, Wilks J, Verstovsek G, et al
    Perineural Invasion Is an Independent Predictor of Outcome in Colorectal Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
32. MONTAGNANI F , Migali C, Fiorentini G
    Progression-Free Survival in Bevacizumab-Based First-Line Treatment for Patients With Metastatic Colorectal Cancer: Is It a Really Good End Point?
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
33. RENNERT G , Rennert HS, Pinchev M, Lavie O, et al
    Use of Hormone Replacement Therapy and the Risk of Colorectal Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. BOOTH CM , Le Maitre A, Ding K, Farn K, et al
    Presentation of nonfinal results of randomized controlled trials at major oncology meetings.
    J Clin Oncol. 2009;27:3938-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. HORNING SJ
    Cancer research and privacy: the problem with being joined at the hip.
    J Clin Oncol. 2009;27:3879-80.
    PubMed     Text format     Related articles   
    
    
    
36. VAN HAZEL GA , Pavlakis N, Goldstein D, Olver IN, et al
    Treatment of Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. HINES RB , Chatla C, Bumpers HL, Waterbor JW, et al
    Predictive Capacity of Three Comorbidity Indices in Estimating Mortality After Surgery for Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. KUEBLER JP
    Radioembolization of Liver Metastases in Patients With Colorectal Cancer: A Nonsurgical Treatment With Combined Modality Potential.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    July 2009
39. CLARET L , Girard P, Hoff PM, Van Cutsem E, et al
    Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. PETERSON DE , Barker NP, Akhmadullina LI, Rodionova I, et al
    Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Recombinant Human Intestinal Trefoil Factor Oral Spray for Prevention of Oral Mucositis in Patients With Colorectal Cancer Who Are Receiving Fluorouracil-Based Chemotherapy.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. SANOFF HK , Sargent DJ, Green EM, McLeod HL, et al
    Racial Differences in Advanced Colorectal Cancer Outcomes and Pharmacogenetics: A Subgroup Analysis of a Large Randomized Clinical Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. GROVER S , Stoffel EM, Mercado RC, Ford BM, et al
    Colorectal Cancer Risk Perception on the Basis of Genetic Test Results in Individuals at Risk for Lynch Syndrome.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. LUBBE SJ , Di Bernardo MC, Chandler IP, Houlston RS, et al
    Clinical Implications of the Colorectal Cancer Risk Associated With MUTYH Mutation.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. SHEN Z , Yang X, Chen L, Hao F, et al
    Sister Mary Joseph's nodule as a diagnostic clue to metastatic colon carcinoma.
    J Clin Oncol. 2009;27:e1-2.
    PubMed     Text format     Related articles   
    
    
    June 2009
45. TSIKITIS VL , Malireddy K, Green EA, Christensen B, et al
    Postoperative Surveillance Recommendations for Early Stage Colon Cancer Based on Results From the Clinical Outcomes of Surgical Therapy Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. WILLETT CG , Duda DG, di Tomaso E, Boucher Y, et al
    Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study.
    J Clin Oncol. 2009;27:3020-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. VORDERMARK D
    Cause-specific colostomy rates after chemoradiotherapy for anal carcinoma: cancer-related versus treatment-related colostomy.
    J Clin Oncol. 2009;27:3064.
    PubMed     Text format     Related articles   
    
    
    
48. KIM GP , Sargent DJ, Mahoney MR, Rowland KM Jr, et al
    Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.
    J Clin Oncol. 2009;27:2848-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. DEBUCQUOY A , Haustermans K, Daemen A, Aydin S, et al
    Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer.
    J Clin Oncol. 2009;27:2751-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. GALLAGHER DJ , Kemeny NE
    Colorectal Hepatic Metastases: Adjuvant Chemotherapy and Survival.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
51. POULTSIDES GA , Servais EL, Saltz LB, Patil S, et al
    Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. AJANI JA
    Chemotherapy and radiation resistance: version 2.0.
    J Clin Oncol. 2009;27:2735-6.
    PubMed     Text format     Related articles   
    
    
    
53. INNOCENTI F , Kroetz DL, Schuetz E, Dolan ME, et al
    Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics.
    J Clin Oncol. 2009;27:2604-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. MATHIJSSEN RH , Gurney H
    Irinogenetics: how many stars are there in the sky?
    J Clin Oncol. 2009;27:2578-9.
    PubMed     Text format     Related articles   
    
    
    May 2009
55. KOPETZ S , Chang GJ, Overman MJ, Eng C, et al
    Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. ROBBINS AS , Pavluck AL, Fedewa SA, Chen AY, et al
    Insurance Status, Comorbidity Level, and Survival Among Colorectal Cancer Patients Age 18 to 64 Years in the National Cancer Data Base From 2003 to 2005.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. BRESLIN TM , Morris AM, Gu N, Wong SL, et al
    Hospital Factors and Racial Disparities in Mortality After Surgery for Breast and Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. WANG YC , Chang PY, Yao NS
    Bone Marrow Necrosis Caused by Metastatic Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
59. KEMENY NE , Huitzil Melendez FD, Capanu M, Paty PB, et al
    Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. HOSKINS JM , McLeod HL
    UGT1A and irinotecan toxicity: keeping it in the family.
    J Clin Oncol. 2009;27:2419-21.
    PubMed     Text format     Related articles   
    
    
    
61. ANDRE T , Boni C, Navarro M, Tabernero J, et al
    Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. VAN CUTSEM E , Labianca R, Bodoky G, Barone C, et al
    Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. O'CONNELL MJ
    Oxaliplatin or Irinotecan As Adjuvant Therapy for Colon Cancer: The Results Are In.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
64. ALLEGRA CJ , Yothers G, O'Connell MJ, Sharif S, et al
    Initial Safety Report of NSABP C-08: A Randomized Phase III Study of Modified FOLFOX6 With or Without Bevacizumab for the Adjuvant Treatment of Patients With Stage II or III Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. JAHN S , Minai-Pour MB, Speicher MR, Reiner-Concin A, et al
    Comprehensive screening for Lynch syndrome: who can be the driving force in daily clinical practice?
    J Clin Oncol. 2009;27:2292.
    PubMed     Text format     Related articles   
    
    
    April 2009
66. LOUPAKIS F , Pollina L, Stasi I, Ruzzo A, et al
    PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. ALLEGRA CJ , Jessup JM, Somerfield MR, Hamilton SR, et al
    American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
    J Clin Oncol. 2009;27:2091-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. CECCHIN E , Innocenti F, D'Andrea M, Corona G, et al
    Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. ADAM R , Wicherts DA, de Haas RJ, Ciacio O, et al
    Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?
    J Clin Oncol. 2009;27:1829-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. KEMENY MM
    How many patients and how many complications does it take to decide if a drug is safe to use before surgery?
    J Clin Oncol. 2009;27:1917-8.
    PubMed     Text format     Related articles   
    
    
    
71. KOPETZ S , Abbruzzese JL
    Hidden biases in an observational study of bevacizumab beyond progression.
    J Clin Oncol. 2009;27:1732-3.
    PubMed     Text format     Related articles   
    
    
    March 2009
72. LUBBE SJ , Webb EL, Chandler IP, Houlston RS, et al
    Implications of Familial Colorectal Cancer Risk Profiles and Microsatellite Instability Status.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. ADAM R , Aloia TA
    Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?
    J Clin Oncol. 2009;27:1343-5.
    PubMed     Text format     Related articles   
    
    
    
74. RUBINSTEIN Y , Dashkovsky I, Cozacov C, Hadary A, et al
    Pseudo meigs' syndrome secondary to colorectal adenocarcinoma metastasis to the ovaries.
    J Clin Oncol. 2009;27:1334-6.
    PubMed     Text format     Related articles   
    
    
    
75. PARK SB , Goldstein D, Lin CS, Krishnan AV, et al
    Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.
    J Clin Oncol. 2009;27:1243-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. BERTAGNOLLI MM , Niedzwiecki D, Compton CC, Hahn HP, et al
    Microsatellite Instability Predicts Improves Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. FIELDS AL , Keller A, Schwartzberg L, Bernard S, et al
    Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. AU HJ , Karapetis CS, O'Callaghan CJ, Tu D, et al
    Health-Related Quality of Life in Patients With Advanced Colorectal Cancer Treated With Cetuximab: Overall and KRAS-Specific Results of the NCIC CTG and AGITG CO.17 Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. SCHMOLL HJ , Arnold D
    When Wishful Thinking Leads to a Misty-Eyed Appraisal: The Story of the Adjuvant Colon Cancer Trials With Edrecolomab.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
80. CHAMBERS SK , Lynch BM, Aitken J, Baade P, et al
    Relationship Over Time Between Psychological Distress and Physical Activity in Colorectal Cancer Survivors.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. SARGENT DJ , Kohne CH, Sanoff HK, Bot BM, et al
    Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. PETRELLI NJ
    Bevacizumab and Postoperative Complications After Hepatic Surgery for Colorectal Metastases.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
83. AJANI JA , Winter KA, Gunderson LL, Pedersen J, et al
    US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
    J Clin Oncol. 2009;27:1116-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
84. OGINO S , Nosho K, Kirkner GJ, Shima K, et al
    PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. KINUGASA Y , Sugihara K
    Why does levator ani nerve damage occur during rectal surgery?
    J Clin Oncol. 2009;27:999-1000.
    PubMed     Text format     Related articles   
    
    
    
86. FIELD KM , Croxford M, Hastie I, Chen F, et al
    Impact of Body Mass Index on Colorectal Cancer Treatment and Outcomes: Need for Prospective and Comprehensive Data.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
87. ELIAS D , Lefevre JH, Chevalier J, Brouquet A, et al
    Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.
    J Clin Oncol. 2009;27:681-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
88. BIBEAU F , Lopez-Crapez E, Di Fiore F, Thezenas S, et al
    Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. NILBERT M , Timshel S, Bernstein I, Larsen K, et al
    Role for genetic anticipation in Lynch syndrome.
    J Clin Oncol. 2009;27:360-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. GRUBER SB , Mukherjee B
    Anticipation in lynch syndrome: still waiting for the answer.
    J Clin Oncol. 2009;27:326-7.
    PubMed     Text format     Related articles   
    
    
    
91. AJANI JA , Izzo JG, Lee JS
    Chemotherapy and radiotherapy resistance: complexity, reality, and promise.
    J Clin Oncol. 2009;27:162-3.
    PubMed     Text format     Related articles   
    
    
    December 2008
92. SCHERUBL H
    Tumor biology and prognosis of gastrointestinal carcinoids.
    J Clin Oncol. 2008;26:6012-3.
    PubMed     Text format     Related articles   
    
    
    
93. WESTIN SN , Lacour RA, Urbauer DL, Luthra R, et al
    Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome.
    J Clin Oncol. 2008;26:5965-71.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: